Related Experiment Video
Updated: Feb 7, 2026

Biodegradable Magnesium Stent Treatment of Saccular Aneurysms in a Rat Model - Introduction of the Surgical Technique
Published on: October 1, 2017
Biodegradable stents for coronary artery disease treatment: Recent advances and future perspectives
Tingzhang Hu1, Chun Yang1, Song Lin1
1Key Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing 400030, China.
Insights
Biodegradable stents (BDSs) offer a promising alternative to metallic stents for treating cardiovascular diseases by reducing long-term side effects. Future research focuses on optimizing BDS structure, materials, and drug delivery for improved performance and patient outcomes.
Area of Science:
- Biomaterials Science
- Cardiovascular Engineering
- Medical Device Development
Background:
- Cardiovascular diseases remain a leading global cause of mortality.
- Metallic endovascular stents, crucial for cardiovascular interventions, face challenges like thrombosis and restenosis.
- Biodegradable stents (BDSs) are emerging as a next-generation solution to mitigate these long-term complications.
Purpose of the Study:
- To review the properties and working principles of various biodegradable stent materials.
- To discuss desirable features and necessary compromises in BDS design, balancing radial support and degradation.
- To outline future research strategies for successful BDS development and application.
Main Methods:
- Literature review summarizing properties of polymeric, iron-, magnesium-, and zinc-based BDSs.
- Analysis of BDS working principles and design considerations.
- Discussion of future research directions including structural optimization, material enhancement, and drug loading.
Main Results:
- Various BDS materials exhibit distinct mechanical properties, degradation rates, and biocompatibility profiles.
- Achieving an optimal balance between radial support and degradation is a key challenge in BDS design.
- Finite element analysis, material improvements, and drug-eluting capabilities are identified as crucial for future BDS development.
Conclusions:
- Biodegradable stents hold significant promise for improving cardiovascular disease treatment by overcoming limitations of metallic stents.
- Further research is essential to optimize BDS structure, mechanical performance, degradation kinetics, and biocompatibility.
- Addressing current limitations will pave the way for successful clinical translation and widespread application of BDSs.
Abstract:
Cardiovascular diseases are one of the major causes of human death in the world. Endovascular stents are the most important implantation devices in cardiovascular intervention, and their efficacy determines the success of cardiovascular disease treatment. In order to reduce the long-term side effects of permanent metallic stents, such as subacute thrombosis and in-stent restenosis, a new generation of endovascular stents so-called "biodegradable stents (BDSs)" is currently being vigorously developed and considered as the most promising candidate. BDS research in the last two decades has been mainly focused on biodegradable polymeric, iron-, magnesium- and zinc-based stent materials. In this review, we first summarized the properties of various BDSs, such as mechanical property, degradation performance, biocompatibility, etc. We then illustrated the working principle of BDSs and their desirable features, which require a compromise between radial support and degradation. We finally discussed the future research strategies in successful BDS development, including the oprimization of stent structures using finite element design, and the improvement in the mechanical properties/corrosion performance/biocompatibility, as well as the drug loading design on BDSs. We also addressed the limitation and deficiency of existing BDSs in order to overcome them in future BDS development and applications.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

